![Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07349-4/MediaObjects/12885_2020_7349_Fig4_HTML.png)
Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using.png)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching | PLOS ONE
![Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology](https://www.thelancet.com/cms/attachment/618e2e54-f852-4d2c-b869-631693d2c1b8/gr1_lrg.jpg)
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis - The Lancet Oncology
![Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data | British Journal of Cancer Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01949-6/MediaObjects/41416_2022_1949_Fig1_HTML.png)
Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data | British Journal of Cancer
![On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value](http://1.bp.blogspot.com/-kUQ4plu5Z10/VetKmGP3SNI/AAAAAAAAAk0/EcsbkS6qlFQ/w1200-h630-p-k-no-nu/image002.gif)
On Biostatistics and Clinical Trials: Understanding the endpoints in oncology: overall survival, progression free survival, hazard ratio, censored value
![Cumulative incidence of overall survival calculated using Kaplan-Meier... | Download Scientific Diagram Cumulative incidence of overall survival calculated using Kaplan-Meier... | Download Scientific Diagram](https://www.researchgate.net/publication/327430144/figure/fig1/AS:667311556026370@1536110881455/Cumulative-incidence-of-overall-survival-calculated-using-Kaplan-Meier-survival-analysis.png)
Cumulative incidence of overall survival calculated using Kaplan-Meier... | Download Scientific Diagram
![Overall survival by RMH score Hazard Ratio = 2.0 (0.9, 4.6) for 1, 2... | Download Scientific Diagram Overall survival by RMH score Hazard Ratio = 2.0 (0.9, 4.6) for 1, 2... | Download Scientific Diagram](https://www.researchgate.net/publication/321628029/figure/fig1/AS:574529491947521@1513989913838/Overall-survival-by-RMH-score-Hazard-Ratio-20-09-46-for-1-2-vs-0.png)
Overall survival by RMH score Hazard Ratio = 2.0 (0.9, 4.6) for 1, 2... | Download Scientific Diagram
![Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis | The BMJ Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis | The BMJ](https://www.bmj.com/content/bmj/375/bmj-2021-066381/F1.medium.jpg)
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis | The BMJ
![10-year Kaplan–Meier overall survival by stage. These data were used to... | Download Scientific Diagram 10-year Kaplan–Meier overall survival by stage. These data were used to... | Download Scientific Diagram](https://www.researchgate.net/publication/49729723/figure/fig1/AS:341619602673676@1458459868845/year-Kaplan-Meier-overall-survival-by-stage-These-data-were-used-to-calculate-the.png)
10-year Kaplan–Meier overall survival by stage. These data were used to... | Download Scientific Diagram
![A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/0fbe43e7-b69c-43d2-bff9-10ce650542f3/gr1.jpg)
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
![Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-07349-4/MediaObjects/12885_2020_7349_Fig1_HTML.png)
Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study | BMC Cancer | Full Text
![Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of](https://ars.els-cdn.com/content/image/1-s2.0-S0959804914008727-fx1.jpg)
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
![Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram](https://www.researchgate.net/profile/Shunsuke-Kondo/publication/259989658/figure/fig4/AS:376440932585476@1466761920292/Progression-free-survival-PFS-curve-and-overall-survival-OS-curve-calculated-using_Q640.jpg)
Progression-free survival (PFS) curve and overall survival (OS) curve... | Download Scientific Diagram
![Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28410-9/MediaObjects/41467_2022_28410_Fig1_HTML.png)